Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-64.42	9.50	26.69
Graham Fair Price	47.21	2.21	1.50
PEG	-98.36	0.03	-1.96
Price/Book	-25.18	2.07	2.77
Price/Cash Flow	-55.08	12.89	28.69
Prices/Earnings	-62.59	3.47	9.28
Price/Sales	-62.59	0.53	1.43
Price/FCF	-55.08	12.89	28.69
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.22	0.22
Operating Margin	0.79	0.06	0.06
ROA	100.00	0.06	0.03
ROE	0.07	0.15	100.00
ROIC	0.05	0.12	135.73
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.12	-0.21	-42.55
Dividends QOQ	-0.47	0.04	-91.20
EBIT QOQ	-0.11	1.02	814.60
EPS QOQ	-0.05	1.08	2185.08
FCF QOQ	-0.05	0.67	1316.56
Revenue QOQ	-0.40	1.00	147.00
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	25.05	12.52	-50.00
Days Sales Outstanding (DSO)	28.04	17.48	-37.66
Inventory Turnover	3.59	7.19	100.00
Debt/Capitalization	0.38	0.28	-27.16
Quick Ratio	0.67	0.83	24.36
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	1.16	1.21	4.09
Cash	< 0.005	< 0.005	4.09
Capex	-0.02	-0.03	-108.19
Free Cash Flow	0.11	0.19	73.38
Revenue	2.25	4.68	108.19
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.29	1.29	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.85	2.38	-51.05
Naive Interpretation	Member

06 - Financial Health · Weak

Rating